Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Ito

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 3, 2009
[Management and treatment of Crohn's disease. 2. Anti-cytokine therapy]Hiroaki Ito
Expert Opinion on Therapeutic Targets|July 23, 2004
Novel therapy for Crohn's disease targeting IL-6 signallingHiroaki Ito
Journal of Gastroenterology|May 21, 2005
Treatment of Crohn's disease with anti-IL-6 receptor antibodyHiroaki Ito
Journal of Gastroenterology|February 5, 2005
Are intestinal microbes our friend or foe?Hiroaki Ito
Current Drug Targets. Inflammation and Allergy|October 17, 2003
IL-6 and Crohn's diseaseHiroaki Ito
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 7, 2012
[Anti tumor necrosis factor alpha antibody: infliximab]Shoko Arimitsu, Hiroaki Ito
Micromachines|July 27, 2022
Editorial for the Special Issue on Advances in Microfluidics for Quantifying Cell Mechanics and BiotransportHiroaki Ito, Naoki Takeishi
Inflammatory Intestinal Diseases|December 14, 2020
Collective Psychology and Behavioral Characteristics of Patients with Inflammatory Bowel Disease: A Single Cohort StudyAi Morimoto, Hiroaki Ito
European Journal of Immunology|September 30, 2011
TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cellsHiroaki Ito, Jessica A Hamerman
Diagnostics (Basel, Switzerland)|January 25, 2025
Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium ValproateMami Uegami, Hiroaki Ito, Tadashi Shiohama
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 3, 2009
[Management and treatment of Crohn's disease. 2. Anti-cytokine therapy]Hiroaki Ito
Expert Opinion on Therapeutic Targets|July 23, 2004
Novel therapy for Crohn's disease targeting IL-6 signallingHiroaki Ito
Journal of Gastroenterology|May 21, 2005
Treatment of Crohn's disease with anti-IL-6 receptor antibodyHiroaki Ito
Journal of Gastroenterology|February 5, 2005
Are intestinal microbes our friend or foe?Hiroaki Ito
Current Drug Targets. Inflammation and Allergy|October 17, 2003
IL-6 and Crohn's diseaseHiroaki Ito
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 7, 2012
[Anti tumor necrosis factor alpha antibody: infliximab]Shoko Arimitsu, Hiroaki Ito
Micromachines|July 27, 2022
Editorial for the Special Issue on Advances in Microfluidics for Quantifying Cell Mechanics and BiotransportHiroaki Ito, Naoki Takeishi
Inflammatory Intestinal Diseases|December 14, 2020
Collective Psychology and Behavioral Characteristics of Patients with Inflammatory Bowel Disease: A Single Cohort StudyAi Morimoto, Hiroaki Ito
European Journal of Immunology|September 30, 2011
TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cellsHiroaki Ito, Jessica A Hamerman
Diagnostics (Basel, Switzerland)|January 25, 2025
Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium ValproateMami Uegami, Hiroaki Ito, Tadashi Shiohama
Pageof 28